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Abstract
What is already known on this topic?
What this study adds?
Objective: Thyroid abnormalities are common in obese children. The aim of the present study was to examine the prevalence of 
subclinical hypothyroidism (SH) and to determine how circulating thyroid hormone concentrations correlate with anthropometrics in 
Danish lean and obese children and adolescents.
Methods: In this cross-sectional study, we included 3006 children and adolescents, aged 6-18 years, from the Registry of the Danish 
Childhood Obesity Biobank. The overweight/obese group (n=1796) consisted of study participants with a body mass index (BMI) 
standard deviation score (SDS) ≥1.28. The control group (n=1210) comprised lean children with a BMI SDS <1.28. All participants were 
characterized by anthropometrics (weight, height, and waist circumference) and fasting serum concentrations of thyroid-stimulating 
hormone (TSH), free triiodothyronine, and free thyroxine (fT4) at baseline. 
Results: The prevalence of SH was higher among overweight/obese compared to lean study participants (10.4% vs. 6.4%, p=0.0001). 
In the overweight/obese group, fasting serum TSH concentrations were associated positively with BMI SDS (p<0.0001) and waist-
height ratio (WHtR) (p<0.0001) independent of age, sex, and pubertal developmental stage, whereas fasting serum fT4 concentrations 
were associated positively only with WHtR. The odds ratio of exhibiting SH was 1.8 when being overweight/obese compared with lean 
(p=0.0007) and 1.8 when presenting with a WHtR >0.5 (p=0.0003).
Conclusion: The prevalence of SH was higher among overweight/obese study participants. The positive correlations of circulating TSH 
and fT4 with WHtR suggest that central obesity, independent of the overall degree of obesity, augments the risk of concurrent thyroid 
abnormalities in children and adolescents with obesity.
Keywords: Childhood obesity, thyroid hormones, waist-height ratio
This study underlines that SH is more prevalent among overweight/obese children compared to their lean peers. We found a positive 
correlation between waist-height ratio (used as a proxy of central fat accumulation) and fasting serum concentrations of thyroid-
stimulating hormone, indicating that central obesity is of importance when evaluating the risk of children with obesity to exhibit thyroid 
abnormalities.
Subclinical hypothyroidism (SH) is a frequent finding in children and adolescents with obesity. Furthermore, SH has been associated 
with increased risk of exhibiting cardio-metabolic disorders. The mechanisms responsible for the disturbances in thyroid hormone 
concentrations during obesity are still unclear.
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Introduction
Thyroid hormones are known to play an important role in 
the regulation of thermogenesis (1,2) and are also involved 
in glucose and lipid metabolism (2,3), making them essential 
determinants of energy expenditure.
It is well known that overt hypothyroidism can lead 
to obesity. Nevertheless, modest alterations in thyroid 
function are more common among obese compared to 
lean children, including elevated serum concentrations of 
thyroid-stimulating hormone (TSH) combined with normal 
serum concentrations of free thyroxine (fT4)-often termed 
subclinical hypothyroidism (SH) (4,5,6,7,8,9). SH is a 
diagnosis of exclusion which does not cause any clinical 
symptoms of hypothyroidism. Whether SH in obesity is 
caused by a reduced thyroid function or reflects an adaptive 
mechanism against obesity in order to increase energy 
expenditure remains to be clarified. Longitudinal studies 
in obese children have reported improvements in thyroid 
status by reductions in TSH concentrations during weight 
loss (10,11) supporting the latter notion; however, results 
have been conflicting (6,12).
SH has been suggested a risk factor for cardiovascular and 
metabolic disorders such as hypertension and dyslipidemia 
(3,13,14). Likewise, central fat accumulation in obese 
children is associated with a range of metabolic comorbidities 
and development of cardiovascular complications (15). 
Although there exist various studies evaluating thyroid 
status in children with obesity, most studies have focused 
on body mass index (BMI) standard deviation score (SDS) 
as the anthropometric measure to describe the degree 
of obesity (5,6,7,14). Few studies have investigated 
associations with other anthropometric measures such 
as waist circumference (WC) (16,17) and waist-hip ratio 
(17). Waist-height ratio (WHtR) has been advocated as an 
effective and convenient measure of central adiposity in 
children that could potentially be superior to BMI SDS in 
estimating cardiovascular and metabolic risk (15,18,19). 
The aim of the present study was to determine the prevalence 
of SH and investigate the fasting serum concentrations 
of thyroid hormones in children and adolescents with 
overweight/obesity and in their lean peers. Furthermore, 
we evaluated how anthropometric measures, including 
WHtR as a proxy of central adiposity, were associated to 
fasting serum concentrations of thyroid hormones, as we 
hypothesized that SH in children could be associated to the 
degree of central adiposity.
Methods 
Study Sample and Design
For this cross-sectional study, we recruited children and 
adolescents from the Registry of the Danish Childhood 
Obesity Biobank. From August 2007 to May 2014, 1854 
overweight/obese children and adolescents were enrolled 
in the chronic care multidisciplinary treatment program 
at The Children’s Obesity Clinic, Department of Pediatrics, 
Copenhagen University Hospital Holbæk, Denmark. 
The chronic care multidisciplinary treatment program is 
furthermore established in eight municipal clinics throughout 
Denmark wherefrom 946 overweight/obese children and 
adolescents were registered from June 2012 to May 2014. 
From June 2011 to May 2014, a control group was recruited 
comprising a population sample of 1979 Danish school 
children from schools in the same geographical regions 
(Capital Region and Region Zealand, Denmark). None of 
the recruitment areas in Denmark are known to suffer from 
iodine deficiency. Inclusion criteria for both groups were: i) 
Age 6-18 years and ii) a fasting blood sample drawn at the 
time of inclusion into the Biobank or at initiation of obesity 
treatment. Overall, the overweight/obese group was defined 
by a BMI SDS ≥1.28, corresponding to the 90th percentile 
according to a Danish age- and sex-adjusted reference 
(20,21). For sub-group analyses, overweight was defined 
as BMI SDS ≥1.28, while obesity was defined as BMI SDS 
≥2.33 (20,21). The lean control group consisted of children 
and adolescents with a BMI SDS <1.28. The exclusion 
criteria were: i) An intake of medications known to affect 
serum concentrations of thyroid hormones (22), ii) a time 
period of more than 60 days between the anthropometric 
measures and the fasting blood sampling, and iii) a serum 
TSH concentration above 10.0 mIU/L or below 0.45 mIU/L, 
both suggestive cut-offs of overt thyroid disease (23,24).
Methods
Study participants were assessed with concomitant 
clinical and biochemical characteristics. The children 
and adolescents recruited from The Children’s Obesity 
Clinic were assessed at treatment enrollment. Clinical 
characteristics included age, sex, height, weight, BMI 
SDS, WC, and pubertal developmental stage. Biochemical 
characteristics included serum concentrations of TSH, fT4, 
and free triiodothyronine (fT3). 
Anthropometry
Anthropometric measures were obtained with the study 
participants wearing light indoor clothing with empty 
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pockets and without shoes. Height was measured to the 
nearest mm using a stadiometer. Weight was measured 
to the nearest 100 grams using a Tanita Digital Medical 
Scale (WB-100 MA, Tanita Corp., Tokyo, Japan). BMI was 
calculated as the weight in kilograms divided by the square 
of the height in meters (kg/m2). BMI SDS was calculated 
using the LMS method (25) by transforming BMI into a 
normal distribution based on a Danish population with the 
same sex and age (20). WC was measured to the nearest 
mm at the end of a normal expiration with a non-elastic 
measuring tape placed at the level of the umbilicus while 
the participant was standing with arms down. WHtR was 
calculated as WC divided by height. 
Pubertal Developmental Stage
Determination of pubertal developmental stage was rated 
according to the classification of Tanner (26,27). A trained 
pediatrician examined the children and adolescents with 
overweight/obesity, while pubertal staging of the lean control 
group was obtained via a questionnaire with picture pattern 
recognition of the five different Tanner stages accompanied 
by a text describing each category. 
Biochemical Measurements
Venous blood samples were drawn from an antecubital 
vein after an overnight fast. If required, a local anesthetic 
cream (lidocaine/prilocaine mixture, Emla, AstraZeneca, 
Stockholm, Sweden) was applied one hour prior to 
venipuncture. The blood samples were analyzed 
immediately after venipuncture. A Cobas 6000® analyzer 
(F. Hoffmann-La Roche Ltd, Basel, Switzerland) was used 
to analyze serum concentrations of TSH and fT4 from 
August 2007 to May 2013. A Dimension Vista/Centaur 
analyzer (Siemens, Munich, Germany) was used to measure 
serum concentrations of TSH, fT4, and fT3 on blood 
samples collected after May 2013, making measures of fT3 
concentrations available in a sub-group of study participants. 
Both analyzers used immunologic chemiluminescent 
assays. The analyzers yielded concordant results and were 
evaluated to be comparable in the analyses of TSH and fT4. 
This was based on a linear relationship (r2=0.985 for fT4 
and r2=0.997 for TSH) between the analyzers and a bias of 
6% for TSH and 13.7% for fT4. Intra-assay coefficients of 
variation were <0.10 for both analyzers. 
Intervals for normal values were set as follows: TSH 0.45-
4.5 mIU/L (23), fT4 11.1-23.4 pmol/L, and fT3 3.62-8.71 
pmol/L based on analyses of a German pediatric population 
comprising 722 children and adolescents (28).
SH was defined as an elevated serum concentration of TSH 
in the range 4.5-10.0 mIU/L combined with a normal serum 
concentration of fT4 (24). Euthyroidism was defined as 
normal serum concentrations of TSH and fT4 alongside no 
clinical signs of hypothyroidism.
Statistical Analysis
Data were analyzed as continuous variables between groups 
by Wilcoxon rank-sum test, and two by two comparisons 
were analyzed by Fisher’s exact test. Multiple linear 
regression models where used to investigate associations, 
and logistic regression models of the binomial family 
were used in the assessment of odds ratios (ORs). Levels 
of significance were set at p<0.05. All statistical analyses 
were performed using “R” statistical software version 3.1.2 
(http://www.r-project.org).
Ethical Aspects 
Informed written consent was obtained from study 
participants aged 18 years and from the parents if the 
participants were younger. Informed assent was obtained 
from all children and adolescents. The study received 
ethical approval by the Ethics Committee of Region Zealand, 
Denmark (ID no. SJ-104) and by the Danish Data Protection 
Agency and was performed in accordance with the ethical 
standards of the Declaration of Helsinki 2013. The present 
study has been reported in line with the STrengthening 
the Reporting of OBservational studies in Epidemiology 
(STROBE) guidelines.
Results
In total, 3114 recruited children and adolescents fulfilled 
the inclusion criteria. Of these, 59 subjects were excluded 
due to intake of medications potentially affecting the 
thyroid hormones, 47 were excluded due to a period of 
more than 60 days between anthropometric measures and 
blood sampling, and two volunteers were excluded due to 
a serum TSH concentration above 10 mIU/L. The remaining 
3006 eligible study participants consisted of 1796 (985 
girls) overweight/obese and 1210 (729 girls) lean children 
and adolescents. Serum fT3 concentrations were available in 
440 overweight/obese (237 girls) and 534 lean children and 
youths (318 girls). Overall, the group of overweight/obese 
children and adolescents had a median BMI SDS of 2.75 
[interquartile range (iqr) 2.22-3.22] and a median age of 
11.6 (iqr 9.5-13.9), while the median BMI SDS in the lean 
group was 0.06 (iqr -0.53-0.61) combined with a median age 
of 12.1 (iqr 9.6-14.9), with the group of lean girls showing a 
higher age than the other groups. Sex-stratified clinical and 
biochemical baseline characteristics are shown in Table 1. 
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The prevalence of SH was higher among overweight/obese 
compared to lean children and adolescents (10.4% vs. 6.4%, 
p=0.0001). Stratifying for sex, the SH prevalence was higher 
in overweight/obese boys than in lean boys, whereas no 
significant difference in the prevalence rates was observed 
when comparing overweight/obese and lean girls (Table 1). 
Overall, the overweight/obese children and youths exhibited 
higher concentrations of serum TSH (p<0.0001) and 
serum fT4 (p<0.0001) when compared with lean children 
and adolescents. Overweight/obese girls had higher serum 
concentrations of TSH, fT4, and fT3 compared to lean girls 
(Table 1). Furthermore, serum TSH concentrations were 
higher in obese as compared with overweight girls (Figure 
1). Serum concentrations of TSH in overweight/obese boys 
were higher than in lean boys (Table 1 and Figure 1). Also 
serum fT4 concentrations were higher in overweight/obese 
boys compared to their lean peers, while no significant 
difference in serum fT3 concentrations was observed 
among boys (Table 1). In the overweight/obese group, boys 
exhibited higher concentrations of serum TSH, fT4, and fT3 
compared to girls (Table 1). The serum fT3 concentration in 
boys with SH was higher than in euthyroid boys and higher 
than in their female peers exhibiting SH (Table 2). 
Overweight/obese children and adolescents had higher 
WHtR (p<0.0001) compared with their lean peers. In the 
overweight/obese group, boys had a significantly higher 
BMI SDS than girls, while there was no sex difference in 
WHtR among the overweight/obese children. Children and 
adolescents having SH had higher BMI SDS (p<0.0001) 
Table 1. Baseline characteristics of 1210 lean and 1796 overweight/obese Danish children and adolescents 
Girls Boys OW/OB 
girls vs. 
boys
Lean girls vs. 
boys
OW/OB Lean p OW/OB Lean p p p
n 985 729 811 481
Age,
years 
11.5
(9.2; 14.1)
12.3
(9.9; 15.3)
<0.0001 11.7
(9.7; 13.6)
11.6
(9.1; 14.3)
0.86 0.62 0.001
BMI SDS 2.61
(2.14; 3.01)
0.06
(-0.55; 0.62)
<0.0001 2.94
(2.35; 3.46)
0.07
(-0.50; 0.58)
<0.0001 <0.0001 0.51
WHtR 0.58
(0.54; 0.63)
0.43
(0.41; 0.45)
<0.0001 0.59
(0.54; 0.63)
0.43
(0.41; 0.45)
<0.0001 0.91 0.64
TSH, mIU/L 2.5
(1.9; 3.5)
2.3
(1.7; 3.1)
<0.0001 2.7
(2.0; 3.6)
2.4
(1.8; 3.2)
<0.0001 0.002 0.24
fT4, pmol/L 14.4
(12.9; 15.9)
14.0
(12.5; 15.7)
0.0005 14.7
(13.2; 16.2)
14.1
(12.5; 15.8)
0.0001 0.01 0.36
fT3, pmol/L 5.7
(5.2; 6.4)
5.5
(4.9; 6.1)
0.02 5.9
(5.6; 6.4)
5.9
(5.5; 6.3)
0.54 0.008 <0.0001
SH, n (%) 91/985
(9.2%)
51/729
(7.0%)
0.11 95/811
(11.7%)
26/481
(5.4%)
0.0002 0.09 0.28
Data are given as medians with interquartile range.
BMI: body mass index, fT3: free triiodothyronine, fT4: free thyroxine, OW/OB: overweight/obese, SDS: standard deviation score, TSH: thyroid-stimulating 
hormone, WHtR: waist-height ratio, SH: subclinical hypothyroidism
Figure 1. Box-plots showing serum concentrations of thyroid-
stimulating hormone in the 3006 Danish lean, overweight, 
and obese boys and girls. TSH: thyroid-stimulating hormone
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and WHtR (p<0.0001) compared with the euthyroid study 
participants (Table 2). In a multivariate regression model 
including all 3006 lean and overweight/obese children and 
youths, serum TSH concentrations were associated positively 
with WHtR (p=0.0009) but not with BMI SDS (p=0.83), 
age (p=0.18), sex (p=0.23), or pubertal developmental 
stage (p=0.82). In the overweight/obese group, serum TSH 
concentrations were associated positively with BMI SDS and 
WHtR separately before and after adjustment for age, sex, 
and pubertal developmental stage in univariate regression 
models (Table 3). A positive correlation was observed in the 
overweight/obese group between serum fT4 concentrations 
and both BMI SDS and WHtR, but only the association 
between serum fT4 and WHtR remained significant 
after adjusting for age, sex, and pubertal developmental 
stage (Table 4). No associations between serum fT3 and 
anthropometrics were found among the overweight/obese 
study participants (Table 5). 
When separately comparing BMI SDS and WHtR with 
the presence of SH in all the 3006 study participants in a 
multiple logistic regression model adjusted for age, sex, 
and pubertal development stage, the OR of exhibiting SH 
Table 2. Baseline characteristics of Danish girls and boys exhibiting subclinical hypothyroidism compared with 
euthyroid girls and boys 
Girls Boys SH
girls vs. boys
Euthyroid 
girls vs. boys
SH Euthyroid p SH Euthyroid p p p
n 142 1467 121 1116
Age, years 11.8
(9.3; 14.6)
11.6
(9.4; 14.4)
0.97 11.1
(8.4; 13.6)
11.6
(9.6; 13.8)
0.03 0.049 0.39
BMI SDS 2.39
(0.52; 2.99)
1.81
(0.25; 2.71)
0.002 2.82
(1.45; 3.57)
2.11
(0.39; 3.11)
<0.0001 0.0006 <0.0001
WHtR 0.55
(0.45; 0.62)
0.52
(0.44; 0.59)
0.004 0.57
(0.48; 0.62)
0.52
(0.44; 0.60)
0.0003 0.25 0.14
TSH, 
mIU/L
5.2 
(4.7; 6.1)
2.3
(1.7; 3.1)
<0.0001 5.2
(4.8; 5.9)
2.5
(1.9; 3.1)
<0.0001 0.82 0.003
fT4, 
pmol/L
14.5
(13.2; 16.0)
14.4
(13.0; 15.9)
0.49 14.7
(13.3; 16.2)
14.6
(13.0; 16.2)
0.97 0.89 0.05
fT3, 
pmol/L
5.6
(5.4; 6.0)
5.8
(5.2; 6.3)
0.63 6.3
(6.0; 6.8)
5.9
(5.5; 6.3)
0.0009 0.0006 0.001
Data are given as medians with interquartile range.
BMI: body mass index, fT3: free triiodothyronine, fT4: free thyroxine, SDS: standard deviation score, SH: subclinical hypothyroidism, TSH: thyroid-stimulating 
hormone, WHtR: waist-height ratio
Table 3. Multiple linear regressions showing the relationship between fasting serum thyroid-stimulating hormone 
concentrations and anthropometrics (n=1796) in the overweight/obese group
Model A Model B
β (SE) r2 p β (SE) r2 p
Basic model 0.01
BMI SDS 0.24 (0.01) 0.02 <0.0001 0.23 (0.05) 0.02 <0.0001
WHtR 2.18 (0.42) 0.02 <0.0001 2.35 (0.46) 0.02 <0.0001
Estimates (β), standard errors (SE), and correlation coefficients (r2) of the relationship between thyroid-stimulating hormone and the anthropometrics body 
mass index standard deviation score and waist-height ratio. The “basic model” compromises age, sex, and pubertal developmental stage. Model A is an 
unadjusted univariate analysis. Model B is a univariate analysis adjusted for age, sex, and pubertal developmental stage. 
BMI: body mass index, SDS: standard deviation score, WHtR: waist-height ratio
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was 1.8 when being either overweight/obese compared to 
lean [95% confidence interval (CI): (1.3; 2.6), p=0.0007] 
or when presenting with a WHtR>0.5 compared to the 
study participants having a WHtR<0.5 [95% CI: (1.3; 2.6), 
p=0.0003].
Discussion
In this cross-sectional study on Danish children and 
adolescents, we observed a higher prevalence of SH among 
overweight/obese compared to lean children and adolescents. 
Concentrations of fasting serum TSH were associated 
positively with both BMI SDS and WHtR in the overweight/
obese group. Independent of the degree of obesity, WHtR 
appeared to have a higher impact on the concentration of 
serum TSH compared with BMI SDS. Furthermore, serum 
fT4  concentrations correlated positively with WHtR but 
not with BMI SDS, while no significant associations were 
found between serum fT3 and either of the anthropometric 
measures. The 10.4% prevalence of SH in study participants 
with overweight/obesity is in accordance with reports from 
previous comparable studies, where prevalence rates of 7 to 
23% have been shown (29). The lower prevalence of SH in 
the lean group was likewise comparable to results of other 
studies (7,9). 
The higher concentrations of serum TSH observed 
among overweight/obese individuals compared with 
lean ones have similarly been observed in other studies 
conducted on overweight/obese children and adolescents 
(5,6,7,8,9,10,14). The literature is less univocal regarding 
data on the concentrations of peripheral thyroid hormones. 
Mostly, elevated concentrations of TSH have been reported in 
combination with elevated concentrations of fT3 (7,10,11,14) 
and slightly decreased (7) or normal fT4 concentrations 
(10,11,14). This is partly in contrast to our results where 
elevated serum fT4 concentrations were found among 
overweight/obese compared to lean children and adolescents, 
whereas serum fT3 concentrations did not differ between 
the two groups. fT3 is known to be the physiologically active 
peripheral thyroid hormone with approximately 80% of 
circulating T3 derived by extrathyroidal monodeiodination of 
T4 (30). A change in the monodeiodination pathway leading 
to augmented concentrations of active fT3, possibly resulting 
in an increased energy expenditure, has been suggested as 
an explanation of the thyroid hormone derangements in 
obesity (7,14,30). A disturbance in the negative feedback 
mechanism regulating the hypothalamus-pituitary-thyroid 
axis has been proposed as another explanation (30). With 
the observed elevated serum concentrations of TSH and fT4 
among overweight/obese compared with lean children in 
Table 4. Multiple linear regressions showing the relationship between fasting serum free thyroxine concentrations and 
anthropometrics (n=1796) in the overweight/obese group
Model A Model B
β (SE) r2 p β (SE) r2 p
Basic model 0.06
BMI SDS 0.20 (0.07) 0.00 0.006 0.09 (0.08) 0.06 0.25
WHtR 1.93 (0.73) 0.00 0.008 2.91 (0.79) 0.07 0.0002
Estimates (β), standard errors (SE), and correlation coefficients (r2) of the relationship between free thyroxine and the anthropometrics body mass index 
standard deviation score and waist-height ratio. The “basic model” compromises age, sex, and pubertal developmental stage. Model A is an unadjusted 
univariate analysis. Model B is a univariate analysis adjusted for age, sex, and pubertal developmental stage. 
BMI: body mass index, SDS: standard deviation score, WHtR: waist-height ratio
Table 5. Multiple linear regressions showing the relationship between fasting serum free triiodothyronine 
concentrations and anthropometrics (n=440) in the overweight/obese group
Model A Model B
β (SE) r2 p β (SE) r2 p
Basic model 0.25
BMI SDS 0.03 (0.05) 0.00 0.47 -0.07 (0.05) 0.25 0.14
WHtR -0.19 (0.54) 0.00 0.72 -0.18 (0.52) 0.25 0.73
Estimates (β), standard errors (SE), and correlation coefficients (r2) of the relationship between free triiodothyronine and the anthropometrics body mass 
index standard deviation score and waist-height ratio. The “basic model” compromises age, sex, and pubertal developmental stage. Model A is an unadjusted 
univariate analysis. Model B is a univariate analysis adjusted for age, sex, and pubertal developmental stage. 
BMI: body mass index, SDS: standard deviation score, WHtR: waist-height ratio
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the present study, our results support the latter notion, as 
people with a normal feedback mechanism and elevated 
concentrations of serum TSH would be expected to have 
decreased concentrations of peripheral thyroid hormones. 
The lacking consistency when evaluating peripheral thyroid 
hormones in obesity could be due to differences in study 
populations, as it has been proposed that thyroid function 
differs between lower grades of overweight and morbid 
obesity (31). The inconsistency could also point towards the 
elevated serum TSH concentrations to be the most pertinent 
thyroid disturbance in obesity. This possibility has previously 
been considered in a study of 226 obese and 39 lean adults, 
where serum TSH was associated with BMI and WC (32). 
TSH has been shown to induce adipogenesis and adipokine 
production (e.g. leptin) directly through TSH receptors in 
adipose tissue, independent of the mediating influence 
of thyroid hormones on energy balance (33). Likewise, 
signalling via leptin receptors has been shown to affect 
the TSH secretion by stimulating pro-thyrotropin-releasing 
hormone receptors in hypothalamus (34). The bidirectional 
signalling indicates a direct interaction between TSH and 
adipose tissue regulated differently from the hypothalamus-
pituitary-thyroid axis and underlines the possibility that 
an elevated serum TSH concentration in obesity is more 
crucial than the varying derangements in peripheral thyroid 
hormone concentrations. 
In line with the elevated serum concentrations of TSH in 
children with obesity, a positive association between TSH 
and BMI SDS has almost consistently been reported in 
previous pediatric studies (6,7,9,11,14,35). We observed a 
positive association between serum TSH and BMI SDS as 
well as between BMI SDS and serum fT
4, whereas serum 
fT3 did not correlate with BMI SDS. Previously, a positive 
association between BMI SDS and serum total T4 has been 
reported in 190 obese children as compared to 133 age- 
and sex-matched controls, while no significant associations 
between BMI SDS and serum fT4 or serum fT3 (9) were 
observed, the latter being compatible with our results.
Few studies have focused on the correlation between thyroid 
variables and anthropometrics other than BMI. A positive 
association between serum TSH and WC has been reported 
in 201 adult euthyroid women (16), whereas another study 
failed to show any association in 703 multiethnic obese 
children and adolescents (3). In a study of 240 pre-pubertal 
children, serum fT3 concentrations were strongly influenced 
by augmented central fat accumulation, measured by dual-
energy x-ray absorptiometry (DXA), independent of total 
body fat mass and percentage of body fat. Augmented 
visceral fat accumulation is associated with the development 
of several cardio-metabolic risk factors (15,18). BMI SDS is 
of limited use in the evaluation of body composition due to 
its inability to differentiate muscle mass from bone and fat 
mass (36). WHtR takes body composition into account by 
evaluating WC in accordance to variability in height, and 
therefore WHtR is considered to be a more appropriate proxy 
of central adiposity compared with BMI SDS (15,18,19). 
Conceivably, in the present study, we included WHtR as a 
surrogate measure of central adiposity. We observed that 
serum TSH associated positively with WHtR and BMI SDS 
among overweight/obese individuals, but when all study 
participants were included in the analysis, serum TSH only 
showed a significant association with WHtR. Additionally, 
the stronger determinant of serum fT4 concentrations 
appeared to be the WHtR among the overweight/obese 
children and adolescents. This finding suggests that an 
augmented WHtR, and thus central obesity, is associated 
with the risk of thyroid dysfunctions. 
A sex difference was demonstrated in the overweight/
obese group, as overweight/obese boys showed higher 
concentrations of thyroid hormones compared with 
overweight/obese girls. Even though we did not see a sex-
specific difference in WHtR, it is possible that the higher 
concentrations of thyroid hormones in boys can be explained 
by a correlation between thyroid hormones and the degree 
of central obesity, as it has been suggested that men 
accumulate more visceral fat than women, independent of 
total body fat mass (37). The proposed difference between 
men and women regarding accumulation of visceral fat is 
biologically plausible for boys and girls as well. We also 
observed serum TSH concentrations to be higher in obese 
compared to overweight and lean girls, while serum TSH 
concentrations in obese and overweight boys were higher 
than in lean boys. This indicates that girls need to become 
relatively more overweight than boys before they show 
corresponding elevated concentrations of TSH. The theory 
of visceral fat to accumulate faster among boys compared 
to girls (37) could contribute to this observed sex difference 
in thyroid-pituitary gland function. Nevertheless, the 
mechanisms explaining thyroid abnormalities in obesity are 
still unclear. Due to the cross-sectional nature of this study, 
we are unable to clarify whether the higher prevalence of SH 
among children and adolescents with overweight/obesity 
plays a pathogenic part in obesity or if rather it reflects an 
adaptive effort to raise energy expenditure.
One limitation of this study is the lack of thyroid antibody 
measurements and the possibility that children with 
autoimmune thyroiditis may have been included in the 
study sample. However, this is not very likely, since all 
patients in the overweight/obese group were evaluated 
clinically by a trained pediatrician regarding their clinical 
thyroid status. Furthermore, other studies conducted on 
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obese children and adolescents have reported positive 
results for thyroid antibodies in 5.7% to 19.5% of obese 
children with SH, concluding that autoimmune thyroiditis is 
rarely the cause of elevated thyroid hormone concentrations 
in obesity (4,5,9). The relative limitation of blood samples 
to be analyzed for serum fT3 concentrations is another 
shortcoming of the present study. Also, the change in 
method used to analyze fT4 and TSH concentrations is a 
limitation. We relied on the quality control performed by our 
laboratory at the time of method change which determined 
reliable correlation coefficients and comparable coefficients 
of variations between the analyzers. Therefore, we believe 
that the fT4 and TSH concentrations measured by the two 
different analyzers are comparable. The maximum interval 
of 60 days between the obtaining of anthropometric 
measurements and the blood sampling allowed for the 
variability caused by the possibility that overweight/obese 
children enrolled in obesity treatment lost or gained weight 
before the blood sample was taken. This could mean that 
the presented result is a conservative estimate of the SH 
prevalence among the overweight/obese group. Yet, an 
additional limitation of the study is the self-reported 
staging of pubertal development of the controls. Tanner 
staging is by its nature an arbitrary measure as it attempts 
to characterize a continuous developmental progress into 
one of five distinct stages and therefore both objectively 
measured and self-reported staging needs to be carefully 
interpreted. The primary strength of this study is that it was 
conducted on a relatively large study population consisting 
of well-characterized overweight/obese and lean children 
and adolescents. 
In conclusion, this study shows that SH is more prevalent 
among children and adolescents with obesity compared to 
their lean peers. Central fat accumulation is related to the 
thyroid abnormality independent of the degree of overall 
obesity, indicating central obesity as an aggravated risk 
for development of SH. Nevertheless, the causality of the 
association remains to be clarified and longitudinal studies 
are needed to understand possible links between SH and 
central fat accumulation.
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